Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
APPA [NASD]
AP Pharma Inc.
Index- P/E- EPS (ttm)-0.20 Insider Own36.26% Shs Outstand40.11M Perf Week-8.70%
Market Cap16.85M Forward P/E- EPS next Y- Insider Trans- Shs Float36.79M Perf Month27.27%
Income-7.68M PEG- EPS next Q- Inst Own50.17% Short Float0.75% Perf Quarter-41.67%
Sales1.24M P/S13.59 EPS this Y58.41% Inst Trans-0.45% Short Ratio0.11 Perf Half Y-20.75%
Book/sh0.06 P/B7.00 EPS next Y- ROA-215.63% Target Price- Perf Year-16.00%
Cash/sh0.08 P/C5.58 EPS next 5Y- ROE-509.99% 52W Range0.28 - 0.89 Perf YTD-23.64%
Dividend- P/FCF- EPS past 5Y- ROI-458.28% 52W High-52.81% Beta0.66
Dividend %- Quick Ratio- Sales past 5Y-25.25% Gross Margin- 52W Low50.00% ATR0.03
Employees29 Current Ratio2.65 Sales Q/Q-68.58% Oper. Margin-828.05% RSI (14)43.42 Volatility10.58% 8.44%
OptionableNo Debt/Eq0.00 EPS Q/Q-6.53% Profit Margin-617.60% Rel Volume0.05 Prev Close0.43
ShortableYes LT Debt/Eq0.00 EarningsMar 28 Payout- Avg Volume2.45M Price0.42
Recom- SMA20-1.18% SMA50-2.96% SMA200-27.97% Volume118,083 Change-2.33%
13-Jun-12Initiated JMP Securities Mkt Outperform $3
10-Sep-08Initiated Ladenburg Thalmann Buy $2.50
12-Jul-07Initiated Dawson James Speculative Buy
19-May-13 08:32PM  SmithOnStocks Opines On Stocks: May 19th Edition at Seeking Alpha
17-May-13 01:04PM  AP PHARMA INC /DE/ Financials EDGAR Online Financials
13-May-13 05:38AM  SmithOnStocks Opines On Recent Biotech News at Seeking Alpha
10-May-13 08:00AM  A.P. Pharma Announces First Quarter 2013 Financial Results and Highlights Recent Corporate Progress Business Wire
07:45AM  AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
07:35AM  AP PHARMA INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
06-May-13 09:21AM  Leaders of TheStreet's Drug Approval Contest at TheStreet
05-May-13 11:03PM  AP PHARMA INC /DE/ Files SEC form 8-K, Unregistered Sale of Equity Securities, Change in Directors or Principal Offic EDGAR Online
03-May-13 08:18AM  A.P. Pharma: Management Change Is A Positive For The Stock at Seeking Alpha
02-May-13 08:03AM  InPlay: AP Pharma announces Barry Quart appointed Chief Executive Officer Briefing.com +13.89%
08:00AM  A.P. Pharma Appoints New Management Team Business Wire
03-Apr-13 04:26PM  More Bio-Run Up Ideas at Seeking Alpha
31-Mar-13 05:12AM  AP Pharma And Ziopharm: The Differences Between Bad News at Seeking Alpha
28-Mar-13 01:10PM  FDA rejects A.P. Pharma anti-nausea drug, stock dips at bizjournals.com -36.21%
10:20AM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
10:05AM  Avoid This Pharma Stock at Motley Fool
09:37AM  A.P. Pharma Receives Complete Response Letter On APF530 at Seeking Alpha
09:27AM  UPDATE 1-AP Pharma's drug for chemo-induced nausea denied approval at Reuters
08:30AM  Webster Financial Corp. Earnings Call scheduled for 8:30 am ET today CCBN
08:30AM  A.P. Pharma Inc. Corporate Update Call scheduled for 8:30 am ET today CCBN
08:20AM  InPlay: A.P. Pharma receives FDA complete response letter for APF530; Co revises projected launch timing from 2H 2013 to 1H 2014, Conf Call to Be Held at 8:30am EST Briefing.com
07:23AM  AP Pharma's drug for chemotherapy-induced nausea denied approval at Reuters
07:00AM  A.P. Pharma Receives FDA Complete Response Letter for APF530 Business Wire
21-Mar-13 09:23AM  [video] The Next Big Thing In Biotech: Decision Week at TheStreet
07-Mar-13 01:04PM  AP PHARMA INC /DE/ Financials EDGAR Online Financials -5.17%
05-Mar-13 08:06PM  New Star Analyst Rankings for AP PHARMA INC StarMine -13.24%
04:56PM  AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04-Mar-13 08:48PM  New Star Analyst Rankings for AP PHARMA INC StarMine
03-Mar-13 06:52PM  New Star Analyst Rankings for AP PHARMA INC StarMine
01-Mar-13 08:00AM  A.P. Pharma Announces Fourth Quarter and Full Year 2012 Financial Results and Highlights Recent Corporate Progress Business Wire
06:11AM  AP PHARMA INC /DE/ Files SEC form 10-K, Annual Report EDGAR Online
28-Feb-13 08:00AM  A.P. Pharma Appoints Jesse Hollingsworth as Vice President of Sales Business Wire
13-Feb-13 01:52PM  PDUFA Dates: How To Find 1 Day Gains Of Up To 74% at Seeking Alpha -5.48%
04-Feb-13 06:00AM  Imminent Catalysts Should Keep Investor Interest Alive For These Pharmaceuticals - Part II at Seeking Alpha
01-Feb-13 07:00AM  Biotech Stock Mailbag: Celsion, Navidea, AP Pharma, Sarepta at TheStreet
31-Jan-13 09:00AM  Undiscovered Companies Announces A Video Interview Of Hidden Bio-Tech Company Immunotech Laboratories PR Newswire
25-Jan-13 11:41AM  A.P. Pharma: PDUFA Date On APF530 Looms And I Am A Buyer at Seeking Alpha
24-Jan-13 10:08AM  Investment Implications Of The Acquisition Of MAP Pharmaceuticals By Allergan at Seeking Alpha
23-Jan-13 08:30AM  Google Trading Higher by 5% Pre-Market After Earnings Beat - Top 5 Volume Stocks Focus List: A.P. Pharma Inc, World Moto Corp, Wuhan General Corp, AMR Corp, Swingplane Ventures PR Newswire
22-Jan-13 08:32AM  A.P. Pharma Run-Up Trade Into FDA Approval Decision at TheStreet +12.50%
16-Jan-13 07:57AM  A.P. Pharma Anticipates FDA Decision On APF530 at Seeking Alpha
10-Jan-13 09:00AM  Stocks on the Move: Augme Technologies Inc., AP Pharma Inc., Lone Star Gold Inc., China Logistics Group Inc. PR Newswire
07-Jan-13 06:11AM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04-Jan-13 04:19PM  AP PHARMA INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online +7.14%
18-Dec-12 01:08PM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
17-Dec-12 08:00AM  A.P. Pharma Makes Key Appointments in Preparation of Potential FDA Approval of Lead Product Candidate, APF530 Business Wire
14-Dec-12 11:35AM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
13-Dec-12 08:04AM  AP Pharma names Mark S. Gelder, M.D., as SVP, Chief Medical Officer theflyonthewall.com
08:00AM  A.P. Pharma Names Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer Business Wire
09-Nov-12 01:04PM  AP PHARMA INC /DE/ Financials EDGAR Online Financials
05-Nov-12 02:35PM  AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
08:00AM  A.P. Pharma Announces Third Quarter 2012 Financial Results and Highlights Recent Corporate Progress Business Wire
19-Oct-12 11:51AM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
18-Oct-12 08:00AM  A.P. Pharma Appoints Robert Rosen as Senior Vice President and Chief Commercial Officer Business Wire
17-Oct-12 02:33PM  A.P. Pharma nausea drug reaccepted by Food and Drug Administration at bizjournals.com
12:57PM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
16-Oct-12 08:00AM  A.P. Pharma Announces PDUFA Action Date for APF530 New Drug Application Resubmission Business Wire
09-Oct-12 07:05AM  AP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up Trades at TheStreet
01-Oct-12 01:57PM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
28-Sep-12 11:23AM  A.P. Pharma: Refiling Of NDA For APF530 Could Cause Price Strength at Seeking Alpha
08:00AM  A.P. Pharma Resubmits New Drug Application for APF530, a Product Candidate for the Prevention of Chemotherapy-Induced Nausea and Vomiting Business Wire
27-Sep-12 08:42AM  A.P. Pharma: New Board Member Brings Great Expertise To Possible Launch Of APF530 at Seeking Alpha
10-Sep-12 04:26PM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  A.P. Pharma Appoints Thomas Pitler, Ph.D. as Vice President of Business Development Business Wire
17-Aug-12 01:04PM  AP PHARMA INC /DE/ Financials EDGAR Online Financials
13-Aug-12 05:23PM  The Funded: Chronos Research, TechShop, AP Pharma at bizjournals.com
10-Aug-12 04:32PM  Alexza Pharmaceuticals Reiterated With An Outperform At JMP Securities at Seeking Alpha -5.88%
09-Aug-12 01:15PM  AP PHARMA INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
03-Aug-12 10:58AM  New Star Analyst Rankings for AP PHARMA INC StarMine
02-Aug-12 08:31AM  AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
08:00AM  A.P. Pharma Announces Second Quarter 2012 Financial Results and Highlights Recent Corporate Progress Business Wire
31-Jul-12 09:44AM  A.P. Pharma adds Robert Rosen to board at bizjournals.com +6.06%
08:31AM  AP PHARMA INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements EDGAR Online
08:00AM  A.P. Pharma Appoints Robert Rosen to Its Board of Directors Business Wire
27-Jul-12 04:06PM  Equity Offering Results In Price Weakness And A Buying Opportunity In A.P. Pharma at Seeking Alpha +6.78%
25-Jul-12 09:26AM  AP PHARMA INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi EDGAR Online -10.61%
08:29AM  InPlay: AP Pharma to raise $53.6 mln in common stock offering Briefing.com
08:26AM  A.P. Pharma to Raise $53.6 Million in Common Stock Offering Business Wire
12-Jul-12 06:11AM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
10-Jul-12 08:05AM  InPlay: AP Pharma announces the allowance of three patents covering APF530 Briefing.com
08:04AM  AP Pharma announces allowance of three patents covering APF530 theflyonthewall.com
08:00AM  A.P. Pharma Announces the Allowance of Three Patents Covering APF530 Business Wire
03-Jul-12 01:30PM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
02-Jul-12 07:18AM  A.P. Pharma: Side Effect Issue With Competitive Drug Is A Huge Positive at Seeking Alpha +5.80%
29-Jun-12 08:04AM  InPlay: AP Pharma announces 'positive' APF530 patient-satisfaction data from Phase 3 Study in patients with chemotherapy-induced nausea and vomiting Briefing.com
08:00AM  A.P. Pharma Announces Positive APF530 Patient-Satisfaction Data from Phase 3 Study in Patients with Chemotherapy-Induced Nausea and Vomiting Business Wire
22-Jun-12 03:53PM  AP PHARMA INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements EDGAR Online
21-Jun-12 09:24AM  A.P. Pharma adds Quart, Davis to its board at bizjournals.com +11.11%
08:00AM  A.P. Pharma Appoints Barry Quart and Stephen Davis to Its Board of Directors Business Wire
20-Jun-12 08:00AM  A.P. Pharma to Present APF530 Patient-Satisfaction Data from Phase 3 Study Business Wire
14-Jun-12 10:31AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
13-Jun-12 03:57PM  REVEALED: New Analyst Stock Coverage to Assess Today at Wall St. Cheat Sheet +9.09%
03:09PM  REVEALED: New Analyst Stock Coverage to Analyze Today at Wall St. Cheat Sheet
10:29AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
03:57AM  Coverage initiated on AP Pharma by JMP Securities Briefing.com
04-Jun-12 01:35PM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
31-May-12 08:00AM  A.P. Pharma Announces Study Finding Continuous Exposure to a 5-HT3 Antagonist Using APF530 Provides Better Emetic Control Business Wire
30-May-12 02:34PM  AP PHARMA INC /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
17-May-12 01:04PM  AP PHARMA INC /DE/ Financials EDGAR Online Financials
10-May-12 03:23PM  AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology. Its lead product candidate is APF530, a Phase III clinical trial product for the prevention of chemotherapy-induced nausea and vomiting. The company's product candidate also includes a Phase II clinical trial product, APF112, which incorporates anesthetic, mepivacaine and is designed to provide relief from post-surgical pain and to minimize the use of morphine-like drugs, or opiates used in the management of post-surgical pain. Its pre clinical product candidate APF580 incorporates an opiate into its Biochronomer technology and is designed to provide analgesia lasting at least seven days from a single injection. A.P. Pharma's Biochronomer technology is also used for various applications in therapeutic areas, including pain management, prevention of nausea, control of inflammation, and treatment of ophthalmic diseases. The company was formerly known as Advanced Polymer Systems, Inc. and changed its name to A.P. Pharma, Inc. in May 2001. A.P. Pharma was founded in 1983 and is based in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SPCH, LLLP10% OwnerJul 25Buy0.5338,095,23820,000,00038,095,238Sep 12 05:05 PM